New Agents for Heart Failure: Sacubitril/Valsartan
HTML-код
- Опубликовано: 12 сен 2024
- Sacubitril/valsartan is a combination neprilysin inhibitor/angiotensin receptor blocker that significantly reduces the risk of all-cause death, cardiovascular death, and heart failure hospitalization, while improving related symptoms